Search Media Items

The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). Often called 'the Voice of CDC,' the MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominately consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians.

The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). Often called 'the Voice of CDC,' the MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominately consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians.

The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). Often called 'the Voice of CDC,' the MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominately consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians.

The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). Often called 'the Voice of CDC,' the MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominately consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians.

Tasas de incidencia del cáncer de vagina asociado al VPH por raza y grupo étnico.

Tasas de incidencia del cáncer de vulva asociado al VPH por raza y grupo étnico.

Diagnóstico de cáncer asociado al VPH por edad.

La vacuna contra el VPH puede prevenir ciertos cánceres y otras enfermedades causados por el virus del papiloma humano (VPH). Vacune a sus hijos a los 11 o 12 años, o tan pronto como pueda si ya tienen 13 años o más

El cáncer de cuello uterino es el cáncer ginecológico más fácil de prevenir con pruebas de detección periódicas y seguimiento de los resultados de las pruebas. Existen dos pruebas de detección que pueden ayudar a prevenir o detectar el cáncer de cuello uterino en las etapas iniciales. Estas son la prueba de Papanicoláu y la prueba del VPH.

Número de casos anuales de cánceres asociados al VPH.